Clinical Trials Logo

Clinical Trial Summary

Raynaud's phenomenon (RP) is a disorder of the digital blood vessels resulting in episodic impairment of blood flow. During an attack of RP which commonly affects the hands and feet these arteries contract briefly which limits the blood flow (this is called a vasospasm) and deprived of blood the skin turns white then blue. The aim of this study is to prove the concept that ORM-12741 can prevent these blood vessel spasms.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01315899
Study type Interventional
Source Orion Corporation, Orion Pharma
Contact
Status Terminated
Phase Phase 2
Start date March 2011
Completion date December 2011

See also
  Status Clinical Trial Phase
Completed NCT00946738 - The Effect of Physical Therapy on Raynaud`s Phenomenon Secondary to Systemic Sclerosis N/A
Completed NCT02050360 - "As Required" Oral Sildenafil in Raynaud's Phenomenon Phase 2/Phase 3
Completed NCT01117298 - A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma Phase 3
Completed NCT02583789 - Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon Early Phase 1
Completed NCT03058887 - The Effects of Exercise in Patients With Systemic Sclerosis N/A
Completed NCT00700518 - Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon Phase 1
Completed NCT02506062 - A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP) N/A
Recruiting NCT01378845 - Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands N/A
Completed NCT00841594 - MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison Phase 1